Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Soleno Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q1 2022
- Shares held
- 48.8M
- −1.85M (−3.7%) vs. Q1 2022
- Total value
- $8.80M
- −$2.44M (−21.7%) vs. Q1 2022
- New holders
- 7
- 7 more added
- Sold out
- 8
- 11 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1,120 | $0 | 0.00% | −1,920−63.2% | Reduced |
| JPMorgan Chase & Co | 94 | $0 | 0.00% | −1,507−94.1% | Reduced |
| Wells Fargo & Company | 651 | $0 | 0.00% | +302+86.5% | Added |
| Royal Bank of Canada | 137 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,100 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 526 | $0 | 0.00% | +526 | New |
| BlackRock Inc. | 5,156 | $1.00K | 0.00% | −125,161−96.0% | Reduced |
| Group One Trading, L.P. | 5,386 | $1.00K | 0.00% | −4,662−46.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,624 | $1.00K | 0.00% | −3,809−51.2% | Reduced |
| Avantax Planning Partners, Inc. | 10,700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Levy Wealth Management Group, LLC | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,724 | $2.00K | 0.00% | +12,724 | New |
| Susquehanna International Group, LLP | 16,843 | $3.00K | 0.00% | +2,166+14.8% | Added |
| Onyx Bridge Wealth Group LLC | 20,000 | $4.00K | 0.00% | +20,000 | New |
| Bollard Group LLC | 34,322 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 42,270 | $8.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 47,726 | $8.00K | 0.00% | +47,726 | New |
| Millennium Management LLC | 46,318 | $9.00K | 0.00% | +46,318 | New |
| UBS Group AG | 54,695 | $10.0K | 0.00% | +54,695 | New |
| Aspiriant, LLC | 57,295 | $11.0K | 0.00% | +40,000+231.3% | Added |
| Virtu Financial LLC | 67,569 | $12.0K | 0.00% | +67,569 | New |
| Warberg Asset Management LLC | 90,000 | $16.0K | 0.01% | +63,000+233.3% | Added |
| Oppenheimer & Co Inc | 98,054 | $18.0K | 0.00% | −134,016−57.7% | Reduced |
| Commonwealth Equity Services, LLC | 100,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 105,481 | $20.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 140,018 | $25.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 149,546 | $28.0K | 0.00% | −59,000−28.3% | Reduced |
| Two Sigma Advisers, LP | 232,000 | $43.0K | 0.00% | −14,400−5.8% | Reduced |
| State Street Corp | 231,741 | $43.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 295,312 | $55.0K | 0.00% | +150,689+104.2% | Added |
| Geode Capital Management, LLC | 488,393 | $90.0K | 0.00% | +58,140+13.5% | Added |
| Renaissance Technologies LLC | 550,131 | $102.0K | 0.00% | +301,931+121.6% | Added |
| Worth Venture Partners, LLC | 1,582,704 | $301.0K | 0.18% | −109,136−6.5% | Reduced |
| Vanguard Group Inc | 2,035,806 | $377.0K | 0.00% | −16,045−0.8% | Reduced |
| Oracle Investment Management Inc | 2,132,000 | $394.0K | 0.12% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 2,646,850 | $489.0K | 0.43% | 00.0% | Unchanged |
| Birchview Capital, LP | 3,676,899 | $680.0K | 0.49% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 6,361,349 | $1.18M | 0.49% | −438,651−6.5% | Reduced |
| Nantahala Capital Management, LLC | 9,436,512 | $1.68M | 0.15% | 00.0% | Unchanged |
| Abingworth LLP | 18,022,602 | $3.17M | 1.01% | 00.0% | Unchanged |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −1,401,400−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −252,154−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −128,454−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −13,387−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,998−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Bray Capital Advisors | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |